153 related articles for article (PubMed ID: 34115958)
41. Attitude and Barriers in Palliative Care and Advance Care Planning in Nonmalignant Chronic Lung Disease: Results From a Danish National Survey.
Sørensen AR; Marsaa K; Prior TS; Bendstrup E
J Palliat Care; 2020 Oct; 35(4):232-235. PubMed ID: 32573354
[TBL] [Abstract][Full Text] [Related]
42. Implementation of the Needs Assessment Tool for patients with interstitial lung disease (NAT:ILD): facilitators and barriers.
Reigada C; Papadopoulos A; Boland JW; Yorke J; Ross J; Currow DC; Hart S; Bajwah S; Grande G; Wells A; Johnson MJ
Thorax; 2017 Nov; 72(11):1049-1051. PubMed ID: 28219955
[TBL] [Abstract][Full Text] [Related]
43. Barriers to specialist palliative care in interstitial lung disease: a systematic review.
Kim JW; Atkins C; Wilson AM
BMJ Support Palliat Care; 2019 Jun; 9(2):130-138. PubMed ID: 30464026
[TBL] [Abstract][Full Text] [Related]
44. Patient autonomy and advance care planning: a qualitative study of oncologist and palliative care physicians' perspectives.
Johnson SB; Butow PN; Kerridge I; Tattersall MHN
Support Care Cancer; 2018 Feb; 26(2):565-574. PubMed ID: 28849351
[TBL] [Abstract][Full Text] [Related]
45. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
Barnes H; Holland AE; Westall GP; Goh NS; Glaspole IN
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010908. PubMed ID: 29297205
[TBL] [Abstract][Full Text] [Related]
46. A scoping review of palliative care outcome measures in interstitial lung disease.
Gersten RA; Moale AC; Seth B; Vick JB; Brown H; Eakin MN; Mathai SC; Danoff SK
Eur Respir Rev; 2021 Sep; 30(161):. PubMed ID: 34348982
[TBL] [Abstract][Full Text] [Related]
47. Management of interstitial lung disease associated with connective tissue disease.
Mathai SC; Danoff SK
BMJ; 2016 Feb; 352():h6819. PubMed ID: 26912511
[TBL] [Abstract][Full Text] [Related]
48. Palliative and end-of-life care in rheumatology: High symptom prevalence and unmet needs.
Cho J; Zhou J; Lo D; Mak A; Tay SH
Semin Arthritis Rheum; 2019 Aug; 49(1):156-161. PubMed ID: 30449652
[TBL] [Abstract][Full Text] [Related]
49. Advance care planning in the palliative phase of people with intellectual disabilities: analysis of medical files and interviews.
Voss H; Vogel A; Wagemans AMA; Francke AL; Metsemakers JFM; Courtens AM; de Veer AJE
J Intellect Disabil Res; 2019 Oct; 63(10):1262-1272. PubMed ID: 31237063
[TBL] [Abstract][Full Text] [Related]
50. Differences in Advance Care Planning and Circumstances of Death for Pediatric Patients Who Do and Do Not Receive Palliative Care Consults: A Single-Center Retrospective Review of All Pediatric Deaths from 2012 to 2016.
Harmoney K; Mobley EM; Gilbertson-White S; Brogden NK; Benson RJ
J Palliat Med; 2019 Dec; 22(12):1506-1514. PubMed ID: 31233350
[No Abstract] [Full Text] [Related]
51. Management of COPD in End-of-Life Care by Spanish Pulmonologists.
Ecenarro PS; Iguiñiz MI; Tejada SP; Malanda NM; Imizcoz MA; Marlasca LA; Navarrete BA
COPD; 2018 Apr; 15(2):171-176. PubMed ID: 29558226
[TBL] [Abstract][Full Text] [Related]
52. Integrating POLST into palliative care guidelines: a paradigm shift in advance care planning in oncology.
Bomba PA; Vermilyea D
J Natl Compr Canc Netw; 2006 Sep; 4(8):819-29. PubMed ID: 16948957
[TBL] [Abstract][Full Text] [Related]
53. Barriers to optimal palliative care of lung transplant candidates.
Colman RE; Curtis JR; Nelson JE; Efferen L; Hadjiliadis D; Levine DJ; Meyer KC; Padilla M; Strek M; Varkey B; Singer LG
Chest; 2013 Mar; 143(3):736-743. PubMed ID: 22922517
[TBL] [Abstract][Full Text] [Related]
54. Oxygen Therapy for Interstitial Lung Disease: Physicians' Perceptions and Experiences.
Khor YH; Goh NSL; McDonald CF; Holland AE
Ann Am Thorac Soc; 2017 Dec; 14(12):1772-1778. PubMed ID: 28796538
[TBL] [Abstract][Full Text] [Related]
55. Advance Care Planning in Community: An Evaluation of a Pilot 2-Session, Nurse-Led Workshop.
Rabow MW; McGowan M; Small R; Keyssar R; Rugo HS
Am J Hosp Palliat Care; 2019 Feb; 36(2):143-146. PubMed ID: 30153741
[TBL] [Abstract][Full Text] [Related]
56. The Adaptation, Face, and Content Validation of a Needs Assessment Tool: Progressive Disease for People with Interstitial Lung Disease.
Boland JW; Reigada C; Yorke J; Hart SP; Bajwah S; Ross J; Wells A; Papadopoulos A; Currow DC; Grande G; Macleod U; Johnson MJ
J Palliat Med; 2016 May; 19(5):549-55. PubMed ID: 26840603
[TBL] [Abstract][Full Text] [Related]
57. Barriers to Use of Palliative Care and Advance Care Planning Discussions for Patients With End-Stage Liver Disease.
Ufere NN; Donlan J; Waldman L; Dienstag JL; Friedman LS; Corey KE; Hashemi N; Carolan P; Mullen AC; Thiim M; Bhan I; Nipp R; Greer JA; Temel JS; Chung RT; El-Jawahri A
Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2592-2599. PubMed ID: 30885884
[TBL] [Abstract][Full Text] [Related]
58. An Interventional Study for the Early Identification of Patients With Palliative Care Needs and the Promotion of Advance Care Planning and Advance Directives.
Yen YF; Lee YL; Hu HY; Lai YJ; Sun WJ; Ko MC; Chen CC; Curtis JR; Huang SJ; Chu D
J Pain Symptom Manage; 2020 May; 59(5):974-982.e3. PubMed ID: 31759033
[TBL] [Abstract][Full Text] [Related]
59. Association of illness understanding with advance care planning and end-of-life care preferences for advanced cancer patients and their family members.
Yoo SH; Lee J; Kang JH; Maeng CH; Kim YJ; Song EK; Koh Y; Yun HJ; Shim HJ; Kwon JH; Nam EM; Kang E; Choo J; Yun YH
Support Care Cancer; 2020 Jun; 28(6):2959-2967. PubMed ID: 31768736
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
